Zynerba Pharmaceuticals Announces Positive Top Line Data from BELIEVE 1 Open Label Phase 2 Study of Zygel™ in Developmental and Epileptic Encephalopathies (DEE)

September 18, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search